Sparrow Pharmaceuticals, Inc.
4 private offerings reported to the SEC on Form D since 2016, $73.3M sold in all. Pharma, OR.
- Form D offerings: 4
- Reported sold: $73.3M
- Newest: Jul 1, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Jul 1, 2025 | $61.8M | $121.4M | Sparrow Pharmaceuticals, Inc.Pharma · OR | Not amended | 0001786949-25-000002 |
| Apr 12, 2024 | $10.0M | $15.3M | Sparrow Pharmaceuticals, Inc.Pharma · OR | Not amended | 0001786949-24-000002 |
| Jan 13, 2021 | $1.1M | $50.8M | Sparrow Pharmaceuticals, Inc.Pharma · OR | Not amended | 0001786949-21-000001 |
| Nov 15, 2019 | $338K | $338K | Sparrow Pharmaceuticals, Inc.Pharma · OR | Jun 26, 2020 | 0001786949-19-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Portland, Or
- Incorporated in
- DE
- All SEC filings
- CIK 1786949 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR